Get started
Author

Chloé Pasin

Observed names: C. Pasin, Chloe Pasin, Chloé Pasin, Pasin, Chloe, Pasin, Chloé, Pasin, Chloé, Pasin, Chloé; https://orcid.org/0000-0001-8730-790X
Observed institutions: École Normale Supérieure Paris-Saclay, Institut national de recherche en sciences et technologies du numérique, Université de Bordeaux, Inserm, Queen Mary University of London, University of Zurich, Université Paris-Saclay, Columbia University Irving Medical Center, University Hospital Zurich, Bordeaux Population Health, Institut de Recherche Vaccinale, Hôpitaux Universitaires Henri-Mondor, Centre Inria de l'université de Bordeaux, Collegium Helveticum, SISTM: Statistics In System biology and Translational Medicine, Blizard Institute
ORCID: 0000-0001-8730-790X
Observed ORCID: 0000-0001-8730-790X
OpenAlex ID: A5058229305
Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19
2021 · Peter A. Szabo, Pranay Dogra, et al. · Immunity · 383
PDF
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation
2022 · Alice Huang, Caroline Cicin-Sain, et al. · Transplantation and Cellular Therapy · 54
PDF
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity
2021 · Irene A. Abela, Chloé Pasin, et al. · Nature Communications · 44
PDF
Dynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation
2019 · Chloé Pasin, Irene Balelli, et al. · Journal of Virology · 42
PDF
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
2022 · Maddalena Marconato, Irene A. Abela, et al. · Journal of Clinical Investigation · 40
PDF
Elicitation and Identification of Properties
2014 · Ingo Steinwart, Chloé Pasin, et al. · ANU Open Research (Australian National University) · 32
PDF
Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination
2018 · Lise Gross, Edouard Lhomme, et al. · International Journal of Infectious Diseases · 31
PDF
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
2022 · Marconato, Maddalena, Abela, Irene A, et al. · PubMed · 27
PDF
A model for establishment, maintenance and reactivation of the immune response after vaccination against Ebola virus
2020 · Irene Balelli, Chloé Pasin, et al. · Journal of Theoretical Biology · 22
Sex and gender in infection and immunity: addressing the bottlenecks from basic science to public health and clinical applications
2023 · Chloé Pasin, Camila R. Consiglio, et al. · Royal Society Open Science · 16
Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV
2022 · Frédérique Chammartin, Katharina Kusejko, et al. · AIDS · 14
Viral rebound kinetics following single and combination immunotherapy for HIV/SIV
2019 · Mélanie Prague, Jeffrey M Gerold, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 12
PDF
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
2024 · Irene A. Abela, Magdalena Schwarzmüller, et al. · mBio · 11
Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity
2025 · Caio Foulkes, Nikolas Friedrich, et al. · PLoS Pathogens · 9
PDF
Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease
2018 · Chloé Pasin, M. Elizabeth Halloran, et al. · PLoS ONE · 9
PDF
Parameter estimation in nonlinear mixed effect models based on ordinary differential equations: An optimal control approach
2023 · Clairon, Quentin, Pasin, Chloé, et al. · HAL (Le Centre pour la Communication Scientifique Directe) · 8
PDF
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity
2021 · Irene A. Abela, Chloé Pasin, et al. · medRxiv · 8
PDF
Controlling IL-7 Injections in HIV-Infected Patients
2018 · Chloé Pasin, François Dufour, et al. · Bulletin of Mathematical Biology · 8
PDF
Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy
2016 · Edouard Lhomme, Laura Richert, et al. · PLoS ONE · 8
PDF
Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering Approach
2022 · Marco Labarile, Tom Loosli, et al. · The Journal of Infectious Diseases · 7
PDF
Adaptive protocols based on predictions from a mechanistic model of the effect of IL7 on CD4 counts
2018 · Laura Villain, Daniel Commenges, et al. · Statistics in Medicine · 7
Patient and public involvement in HIV research: a mapping review and development of an online evidence map
2024 · David Jackson‐Perry, Ellen Cart‐Richter, et al. · Journal of the International AIDS Society · 6
PDF
Impact of hormonal therapy on HIV ‐1 immune markers in cis women and gender minorities
2024 · Chloé Pasin, David Garcia Nuñez, et al. · HIV Medicine · 5
PDF
Antibody response to a third SARS‐CoV‐2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation
2022 · Andriyana K. Bankova, Chloé Pasin, et al. · British Journal of Haematology · 5
PDF
Variable selection methods for predicting clinical outcomes following allogeneic hematopoietic cell transplantation
2021 · Chloé Pasin, Ryan H. Moy, et al. · Scientific Reports · 5
PDF
Works count: 98
Citation count: 861
H-index: 12
I10-index: 13
Year
Topic
Type